Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

Kui Li; Masaki Mandai; Junzo Hamanishi; Noriomi Matsumura; Ayako Suzuki; Haruhiko Yagi; Ken Yamaguchi; Tsukasa Baba; Shingo Fujii; Ikuo Konishi

首页> 外文期刊>Cancer Immunology, Immunotherapy >Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

【24h】

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

机译：NKG2D配体，MICA / B和ULBP2在卵巢癌中的临床意义：ULBP2的高表达是不良预后的指标

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective To investigate the clinical significance of the expression of the NKG2D ligands MICA/B and ULBP2 in ovarian cancer.

机译：目的探讨NKG2D配体MICA / B和ULBP2在卵巢癌中的表达及其临床意义。

著录项

来源
《Cancer Immunology, Immunotherapy》 |2009年第5期|p.641-652|共12页
作者
Kui Li; Masaki Mandai; Junzo Hamanishi; Noriomi Matsumura; Ayako Suzuki; Haruhiko Yagi; Ken Yamaguchi; Tsukasa Baba; Shingo Fujii; Ikuo Konishi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: High expression of ULBP2 is an indicator of poor prognosis [J] . LiK., MandaiM., HamanishiJ., Cancer immunology, immunotherapy : . 2009,第5期

机译：NKG2D配体，MICA / B和ULBP2在卵巢癌中的临床意义：ULBP2的高表达是预后不良的指标
2. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. [J] . Paschen A, Sucker A, Hill B Clinical cancer research: an official journal of the American Association for Cancer Research . 2009,第16期

机译：黑色素瘤中单个NKG2D配体的差异临床意义：可溶性ULBP2作为不良预后的指标优于S100B。
3. ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients. [J] . McGilvray RW, Eagle RA, Rolland P, International Journal of Cancer =: Journal International du Cancer . 2010,第6期

机译：ULBP2和RAET1E NKG2D配体是卵巢癌患者预后不良的独立预测因子。
4. Ido serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells [C] . Aikou Okamoto, Takashi Nikaido, Kazunori Ochia International Study Group for Tryptophan Research . 2007

机译：IDO用作浆液性卵巢癌细胞基因表达谱中预后不良的标志物
5. Expression, regulation, and function of the KIT tyrosine kinase receptor and its ligand, stem cell factor, in human epithelial ovarian cancer. [D] . Tonary, Angela Marie. 2001

机译：KIT酪氨酸激酶受体及其配体，干细胞因子在人上皮性卵巢癌中的表达，调控和功能。
6. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma [O] . Yuanji Xu, Lin Zhou, Jingfeng Zong, 2017

机译：NKG2D配体ULBP4的表达降低可能是鼻咽癌患者预后不良的指标
7. ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients [O] . Roger W. McGilvray, Robert A. Eagle, Phil Rolland, 2010

机译：ULBP2和RAET1E NKG2D配体是卵巢癌患者预后不良的独立预测因素

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

摘要

著录项

相似文献

相关主题

期刊订阅